Recombinant herpes zoster vaccine
Showing 26 - 50 of >10,000
Herpes Zoster (HZ), Shingles, Infectious Disease Trial in Hollywood, Tampa, Berlin (JCXH-105, Active Control (Shingrix))
Recruiting
- Herpes Zoster (HZ)
- +2 more
- JCXH-105
- Active Control (Shingrix)
-
Hollywood, Florida
- +2 more
May 23, 2023
Influenza, Herpes Zoster Trial in Nijmegen (Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern
Active, not recruiting
- Influenza
- Herpes Zoster
- Herpes zoster vaccination (Shingrix, GSK)
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University
May 19, 2022
COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response Trial in Netherlands (COVID-19 vaccination)
Not yet recruiting
- COVID-19 Vaccines
- +3 more
- COVID-19 vaccination
-
Nijmegen, Gelderland, Netherlands
- +6 more
Jun 29, 2023
Systemic Lupus Erythematosus Trial in New York, Oklahoma City (Herpes Zoster Subunit (HZ/su) Vaccine, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Herpes Zoster Subunit (HZ/su) Vaccine
- Placebo
-
New York, New York
- +1 more
Jan 6, 2023
Herpes Virus Infections in Kidney Transplant Patients
Recruiting
- Kidney Transplant; Complications
- +2 more
-
Aarhus, Denmark
- +4 more
Jan 30, 2023
Herpes Zoster Trial in India (HZ/su, Placebo)
Active, not recruiting
- Herpes Zoster
- HZ/su
- Placebo
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Jan 6, 2023
Varicella Zoster Vaccine Trial in Toronto (VZV subunit vaccine)
Unknown status
- Varicella Zoster Vaccine
- VZV subunit vaccine
-
Toronto, Ontario, CanadaUniversity Health Network, Toronto General Hospital, Multi-Organ
Oct 16, 2020
Herpes Zoster Trial in Tartu (HZ/su vaccine)
Recruiting
- Herpes Zoster
- HZ/su vaccine
-
Elkridge, Maryland
- +47 more
Jan 6, 2023
Varicella Zoster Vaccine Trial in Toronto (recombinant subunit Herpes zoster vaccine)
Completed
- Varicella Zoster Vaccine
- recombinant subunit Herpes zoster vaccine
-
Toronto, Ontario, CanadaUniversity Health Network, Toronto General Hospital, Multi-Organ
Aug 4, 2020
Herpes Zoster Trial in Tomball (HZ/su, Flu D-QIV, mRNA-1273)
Active, not recruiting
- Herpes Zoster
- HZ/su
- +2 more
-
Tomball, TexasGSK Investigational Site
Apr 8, 2022
Herpes Zoster, Shingles Trial in San Antonio (CRV-101 Vaccine Antigen High Dose, CRV-101 Vaccine Antigen Low Dose, Shingrix)
Recruiting
- Herpes Zoster
- Shingles
- CRV-101 Vaccine Antigen High Dose
- +2 more
-
San Antonio, TexasClinical Trials of Texas
Mar 22, 2022
Shingles, Herpes Zoster Trial in Aurora (Zostavax, HZ/su vaccine, Placebo)
Completed
- Shingles
- Herpes Zoster
- Zostavax
- +2 more
-
Aurora, ColoradoPediatric Infectious Diseases and Clinical Trials, Universtiy of
Jul 7, 2020
Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)
Not yet recruiting
- Bone Marrow Transplant
- Stem Cell Transplant
- Zoster Vaccine Recombinant
-
Aurora, ColoradoUniversity of Colorado Hospital
Mar 17, 2023
Herpes Zoster Trial in Nanjing, Hanzhou (live attenuated zoster vaccine, )
Completed
- Herpes Zoster
- live attenuated zoster vaccine
- placebo
-
Nanjing, Jiangsu, China
- +1 more
Dec 6, 2021
Shingles, Herpes Zoster, Vaccine-Preventable Diseases Trial in Australia (Z-1018, Shingrix)
Recruiting
- Shingles
- +2 more
- Z-1018
- Shingrix
-
Blacktown, New South Wales, Australia
- +3 more
Feb 8, 2022
Shingles, Herpes Zoster Infection, Human Trial (Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection,
Not yet recruiting
- Shingles
- +2 more
- Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
- +6 more
- (no location specified)
Jan 19, 2023
RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)
Not yet recruiting
- RZV Vaccine (Shingrix ®)
- Recombinant Zoster Vaccine
-
Bordeaux, France
- +7 more
Oct 27, 2022
Achalasia Trial (ValACYclovir 1000 MG, Shingrix)
Not yet recruiting
- Achalasia
- ValACYclovir 1000 MG
- Shingrix
- (no location specified)
Jan 17, 2023
Long-term Immunogenicity ofLive Herpes Zoster Vaccine in
Recruiting
- Lupus Erythematosus
- Immunogenicity
-
Hong Kong, ChinaDepartment of Medicine, Tuen Mun Hospital
Dec 18, 2021
Trained Immunity in COVID-19 Vaccinated Individuals
Recruiting
- Zoster Varicella
- Vaccination; Infection
- recombinant adjuvanted zoster vaccine
-
Wuerzburg, Bavaria, GermanyUniversity Hospital Wuerzburg
Jan 26, 2023
Varicella Zoster Virus Infection Trial (MG1111)
Not yet recruiting
- Varicella Zoster Virus Infection
- MG1111
- (no location specified)
Dec 16, 2022
Varicella Trial in Chuzhou, Lishui, Quzhou (Live attenuated varicella vaccine)
Not yet recruiting
- Varicella
- Live attenuated varicella vaccine
-
Chuzhou, Anhui, China
- +2 more
Jul 12, 2022
Herpes Zoster Trial in Worldwide (Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A), Placebo)
Active, not recruiting
- Herpes Zoster
- Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)
- Placebo
-
Tallinn, Estonia
- +43 more
Nov 14, 2022
Pain, Quality of Life, Injection Site Reaction Trial in Durham (FLUAD® Quadrivalent, Fluzone® HD Quadrivalent, SHINGRIX®)
Recruiting
- Pain
- +3 more
- FLUAD® Quadrivalent
- +2 more
-
Durham, North CarolinaDuke University
Jan 19, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023